A study published in the Journal of the American Medical Association (JAMA) advises healthcare professionals to actively discuss alternative tobacco products – including e-cigarettes, heated tobacco, and nicotine pouches – as evidence-based tools to help adult smokers quit combustible cigarettes through shared decision-making.
- Evidence-Based Support: Researchers urge US clinicians to provide clear guidance on smoke-free options for patients who struggle to quit smoking.
- Shared Decision-Making: Consultations must weigh individual patient health goals against the relative risk profiles of each product.
- Oral Health Indicators: Clinical research shows switching to smoke-free alternatives improves biological markers in the oral cavity, including higher antioxidant capacity and lower cellular inflammation.
Healthcare providers should include smoke-free nicotine alternatives in cessation discussions with adult smokers, according to a study published in the Journal of the American Medical Association (JAMA). Led by Eleanor L. S. Leavens of the University of Kansas Cancer Center, the research urges medical practitioners to adopt tailored, evidence-based approaches to tobacco harm reduction.
Shared Decision-Making in Clinical Practice
The study highlights that while alternative tobacco products are not entirely risk-free, they present a viable pathway away from combustible cigarettes, which release thousands of toxic compounds upon burning.
“There is no single approach that works for every smoker,” said Leavens. “However, by providing adult smokers with a range of options and engaging them in discussions about the risks and benefits, they have a higher chance of successfully quitting smoking and potentially improving their overall health.”
Leavens emphasized that clinicians need practical tools to guide patients across different product categories, such as nicotine vapes, heated tobacco systems, and nicotine pouches, each carrying distinct usage traits and risk profiles.
Oral Health Improvements for Switchers
The clinical relevance of risk-proportionate approaches extends directly to dentistry and oral biology. Dr. Indra Mustika, a researcher at the Faculty of Dentistry at Universitas Padjadjaran, stressed that health workers must communicate risk levels objectively rather than simply labeling products as “safe” or “unsafe.”
“If adult smokers have attempted to quit and failed, clinicians need to explain that completely switching to alternative tobacco products carries lower risk than continuing to smoke,” Dr. Mustika noted.
Dr. Mustika pointed to clinical data evaluating smokers who transitioned to smoke-free alternatives. The findings revealed measurable biological improvements in oral tissues:
- Increased TAOC: Higher Total Antioxidant Oxidative Capacity levels in the oral cavity.
- Reduced TNF-α: Decreased tumor necrosis factor-alpha, indicating lower tissue inflammation.
- Fewer Micronucleated Cells (MNC): A reduction in chromosomal damage markers among switchers compared to continuing smokers.
These biological markers demonstrate that risk communication rooted in scientific evidence can help adult smokers make informed decisions to reduce tobacco-related harm.
